Target intelligence / Profile preview

Extracellular Matrix Proteins and Cell-Surface Adhesion Molecules (ECM & CAMs) (ECM & CAMs)

Target
ECM & CAMs
Molecular classification
Other, Receptor, Enzyme, Structural protein
01

Overview

Extracellular Matrix (ECM) Proteins and Cell-Surface Adhesion Molecules (CAMs) represent a broad functional class of molecules essential for tissue architecture and intercellular communication. The ECM consists of a complex network of macromolecules, such as collagens, proteoglycans, and glycoproteins, which provide structural support and biochemical signals to surrounding cells (Ref: PMID: 22219366). CAMs, including integrins, cadherins, and selectins, are transmembrane proteins that facilitate physical connections between cells or between a cell and the ECM, playing pivotal roles in cell signaling and migration (Ref: PMID: 11252105). In pathological states, alterations in ECM composition or CAM expression contribute to tumor metastasis, chronic inflammatory infiltration, and the development of fibrosis (Ref: PMID: 24507509). Therapeutic interventions targeting these molecules, such as monoclonal antibodies against specific integrins, are widely used to treat autoimmune disorders and prevent thrombotic events by modulating cell recruitment and adhesion (Ref: PMID: 28853167). Additionally, enzymatic targeting of the ECM is employed in conditions like Dupuytren's contracture to restore tissue flexibility (Ref: PMID: 20163212).

Other names
ECM proteinsCell adhesion moleculesCAMsMatrisome componentsAdhesion receptorsExtracellular matrix components
02

Mechanism of action

Inhibition of integrin-mediated cell adhesion, blockade of leukocyte extravasation, competitive inhibition of ligand binding to cell-surface receptors, and enzymatic degradation of structural matrix proteins.

03

Biological functions

Cell adhesionSignal transductionCell migrationTissue organizationWound healingImmune cell trafficking
04

Disease associations

CancerInflammationFibrosisCardiovascular diseaseAutoimmune disease
05

Safety considerations

Progressive multifocal leukoencephalopathy (PML)Increased susceptibility to infectionsImpaired wound healingBleeding complicationsHypersensitivity reactions
06

Interacting drugs

Natalizumab

6 more in the full profile.

07

Biomarkers

Soluble ICAM-1Soluble VCAM-1Circulating fibronectinCollagen degradation products (e.g., C-terminal telopeptide)Pro-C3

Beyond the preview

Go deeper on Extracellular Matrix Proteins and Cell-Surface Adhesion Molecules (ECM & CAMs) (ECM & CAMs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Extracellular Matrix Proteins and Cell-Surface Adhesion Molecules (ECM & CAMs) (ECM & CAMs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call